T138067 Sodium in Treating Patients With Advanced Refractory Cancer
Status:
Completed
Trial end date:
2001-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase I trial to study the effectiveness of T138067 sodium in treating patients with
advanced refractory cancer.